Daily Values

Growth Metrics

Others

Ratios

Asset Utilization Ratio Assets Average EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Invested Capital Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Invested Capital Return on Sales

Maze Therapeutics (MAZE) Return on Invested Capital (2025)

Maze Therapeutics has reported Return on Invested Capital over the past 1 years, most recently at 0.39% for Q4 2025.